HealthEquity Inc (HQY)
Payables turnover
Jan 31, 2025 | Jan 31, 2024 | Jan 31, 2023 | Jan 31, 2022 | Jan 31, 2021 | ||
---|---|---|---|---|---|---|
Cost of revenue | US$ in thousands | 843,849 | 714,614 | 713,683 | 685,217 | 599,701 |
Payables | US$ in thousands | 14,361 | 12,041 | 13,899 | 27,541 | 1,614 |
Payables turnover | 58.76 | 59.35 | 51.35 | 24.88 | 371.56 |
January 31, 2025 calculation
Payables turnover = Cost of revenue ÷ Payables
= $843,849K ÷ $14,361K
= 58.76
The payables turnover ratio for HealthEquity Inc has showcased fluctuations over the years. Starting at a robust 371.56 in January 2021, the ratio experienced a significant decrease to 24.88 by January 2022, indicating a notable slowdown in the company's ability to pay off its accounts payable. However, there was a notable improvement in the payables turnover ratio in the following years, reaching 51.35 in January 2023, 59.35 in January 2024, and 58.76 in January 2025, demonstrating a better efficiency in managing its payables during these periods. Overall, while there was an initial dip, HealthEquity Inc managed to enhance its payables turnover efficiency in subsequent years, which is a positive indication of its financial management efforts.
Peer comparison
Jan 31, 2025